Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

R-azasetron besylate

EU orphan designation number: EU/3/16/1785   
Active ingredient: R-azasetron besylate
Indication: Treatment of sudden sensorineural hearing loss
Sponsor: Sensorion
375 rue du Professeur Blayac, 34080 Montpellier, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/11/2016 Orphan designation EMA/OD/114/16 (2016)7629 of 18/11/2016